The tape's got that hungover vibe today, with SPY dipping 0.13% to $676.33, barely a scratch but enough to remind you last week's rally wasn't free. QQQ's holding steadier at $607.69, down just 0.01%, like it's nursing a lighter buzz while the broader market sweats the details. I've seen this setup before—minor pullbacks testing the conviction of the bulls, especially with SPY flirting below its 20-day SMA of $683.68.
Under the hood, it's all about that whisper of caution; no big blows, but the air feels thick, like waiting for the other shoe to drop. QQQ's clinging to its 20-day at $606.49, suggesting tech's not ready to fold yet. If I were still on the desk, I'd say this is the market's way of pricing in some macro indigestion without committing to a full purge.
| Ticker | TA Score | Mode | S1 | S2 | R1 | R2 |
|---|---|---|---|---|---|---|
| SPY | 5/10 | IMPROVING | [{'tag': 'S1', 'price': 648.96, 'label': 'Support', 'type': 'sr', 'pct': '-4.0%', 'action': 'Add'}, {'tag': 'S2', 'price': 568.82, 'label': 'Support', 'type': 'sr', 'pct': '-15.9%', 'action': 'Strong add'}, {'tag': 'S3', 'price': 480.59, 'label': 'Support', 'type': 'sr', 'pct': '-28.9%', 'action': 'Max buy zone'}] | 669.39 | N/A | N/A |
| QQQ | 6/10 | IMPROVING | [{'tag': 'S1', 'price': np.float64(607.23), 'label': 'EMA13', 'type': 'ema', 'pct': '-0.1%', 'action': 'Add'}, {'tag': 'S2', 'price': np.float64(606.97), 'label': 'EMA9', 'type': 'ema', 'pct': '-0.1%', 'action': 'Strong add'}, {'tag': 'S3', 'price': 580.08, 'label': 'Support', 'type': 'sr', 'pct': '-4.5%', 'action': 'Max buy zone'}] | 596.11 | N/A | N/A |
| Ticker | SMA 20 | SMA 50 | SMA 200 |
|---|---|---|---|
| SPY | 683.68 | 687.31 | 681.4 |
| QQQ | 606.49 | 614.32 | 614.59 |
For SPY, eyes on that bull scenario trigger at $679.81—break it with volume, and we're eyeing $681.23 like a sprinter spotting the finish line. Supports are stacked lower: $648.96 as first add zone down 4%, then $568.82 for strong adds if it really cracks. No resistances screaming yet, which tells me the path of least resistance might still be up, but watch that improving 5/10 score like a hawk; it's whispering recovery without yelling it.
QQQ's got tighter lines, with EMAs at $607.23 and $606.97 basically at your feet—minor dips there scream add opportunities before the real pain at $580.08 down 4.5%. Bull break above $608.28 targets $609.09, and with a 6/10 improving mode, this feels like tech's got one foot on the gas, waiting for confirmation. I'd watch these like my old PM watched his coffee levels—lose 'em, and the day's narrative flips.
Want the exact option plays behind these signals?
Our AI scans 200+ tickers daily for the highest-conviction setups.
Become a Founding Member — $39.99/moVIX popped 1.77% to $24.66, like a fire alarm that's not quite blaring but definitely chirping louder, signaling nerves are fraying amid the calm. Yields on the 10-year jumped 1.74% to 4.21%, dollar ticked up 0.06% to 99.29, and gold edged 0.33% to $5184.7—it's all pointing to a market bracing for stickier inflation or Fed hawkishness, like guests at a party sensing the host might cut the music early.
Our proprietary model is flagging unusual activity in select names, like high-beta plays showing bullish institutional flows that scream smart money piling in, while healthcare spots flash bearish with elevated put action hinting at downside bets—keep an eye out, these could be the sparks that light up the tape.
Traders, zero in on that VIX creep—it's the market's pulse, and if it spikes further, those support levels become your best friends. I've seen enough cycles to know ignoring the fear gauge is like betting against gravity. Play the breaks, not the hopes.
Unlock Full Access
Get daily Top 10 option plays with conviction scoring, flow breakdowns, and entry/exit levels.
Plus: Interactive dashboard, dark pool signals, and priority alerts.
Join as Founding Member — $39.99/moDisclaimer: This content is for informational and educational purposes only. It is NOT financial advice. Trading options involves significant risk of loss. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.